PCC0208009 50 mg | 99.89%
TargetMol
PCC0208009 (IDO-IN-2) is an IDO inhibitor extracted from patent WO/2015031295 A1, compound example 1.
More Information Supplier PagePCC0208009
Search Results
NSC 80538 2 mg | 99.50%
TargetMol
NSC 80538 is a chemical compound that has been studied for its potential applications in scientific research. NSC 80538 is a member of the thiourea family.
More Information Supplier PageNSC 80538
UNC0642 100 mg | 98.75%
TargetMol
UNC0642 is an effective and specific G9a/GLP inhibitor (IC50< 2.5 nM).
More Information Supplier PageUNC0642
UNC0642 25 mg | 98.75%
TargetMol
UNC0642 is an effective and specific G9a/GLP inhibitor (IC50< 2.5 nM).
More Information Supplier PageUNC0642
UNC0642 2 mg | 98.75%
TargetMol
UNC0642 is an effective and specific G9a/GLP inhibitor (IC50< 2.5 nM).
More Information Supplier PageUNC0642
CY-09 25 mg | Purity Not Available
TargetMol
CY-09
CY-09 1 mg | Purity Not Available
TargetMol
CY-09
PCC0208009 100 mg | 99.89%
TargetMol
PCC0208009 (IDO-IN-2) is an IDO inhibitor extracted from patent WO/2015031295 A1, compound example 1.
More Information Supplier PagePCC0208009
JNK-IN-7 1 mg | 99.58%
TargetMol
JNK-IN-7 is a selective JNK1/2/3 inhibitor (IC50: 1.54/1.99/0.75 nM). It can also inhibit phosphorylation of c-Jun, which is a substrate of JNK kinase.
More Information Supplier PageJNK-IN-7
JNK-IN-7 25 mg | 99.58%
TargetMol
JNK-IN-7 is a selective JNK1/2/3 inhibitor (IC50: 1.54/1.99/0.75 nM). It can also inhibit phosphorylation of c-Jun, which is a substrate of JNK kinase.
More Information Supplier PageJNK-IN-7